DGX Quest Diagnostics Incorporated
$245.62▲ +1.26%
Healthcare
Other
After hours
$245.62▲ +0.00%
Oct 28, 5:05 PM ET
Volume 932.8K
Avg Volume (10D) 1.07M
Key Metrics & Fundamentals
Market Cap
$27.11B
P/E Ratio
24.5
Div Yield
1.42%
52W Range
171.18 - 249.73
% vs 50 MA
3.16%
% vs 200 MA
16.16%
RSI-14
63.3
MACD Histogram
+1.3500
Beta (1Y vs SPY)
-0.11
Free Cash Flow
$445.00M
Gross Rev
$3.10B
Gross Profit
$1.04B
EBITDA
$630.00M
COGS
$2.06B
Operating Exp
$563.00M
Operating Income
$479.00M
EBIT
$479.00M
Pretax Income
$416.00M
Net Income
$312.00M
EPS (Diluted)
2.78
Price & Volume History
Loading chart…
Recent News
Can Hims & Hers Stock Fall 30%?
Trefis · Oct 28, 2026 9:47 AM ET
Evercore ISI Adjusts Price Target on Quest Diagnostics to $240 From $235
MT Newswires · Oct 28, 2026 7:35 AM ET
Will DaVita's Q3 Earnings Reflect Improving Treatment Growth Trends?
Zacks · Oct 27, 2026 11:28 AM ET
Rothschild & Co Redburn Adjusts Price Target on Quest Diagnostics to $279 From $251
MT Newswires · Oct 27, 2026 6:16 AM ET
Quest Diagnostics (DGX) Stock Price Stalls After Strong Q3 Earnings
Simply Wall St. · Oct 23, 2026 11:14 PM ET
Quest Diagnostics (DGX) Backs At Home Cervical Cancer Screening
Simply Wall St. · Oct 23, 2026 7:12 PM ET
Quest Diagnostics (DGX) Stock Could Be Undervalued Despite Raised Full Year Guidance
Simply Wall St. · Oct 23, 2026 1:15 PM ET
Lab testing giant Quest Diagnostics confirms patients’ personal and health data was compromised during breach
TechCrunch · Oct 23, 2026 11:00 AM ET
Western Digital's Q1 Earnings & Revenues Beat, Dividend Hiked by 17%
Zacks · Oct 23, 2026 8:37 AM ET
Deutsche Bank Adjusts Quest Diagnostics PT to $245 From $232, Maintains Hold Rating
MT Newswires · Oct 23, 2026 8:07 AM ET
Financial Overview - Income Statement
Quarterly
Sep 2026
See DGX's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.